For the Inventor, By the Inventor

Enter assignee name

Zenyaku Kogyo Kabushiki Kaisha

USPTO Granted Patents = 41

CIPO Patents = 8

EPO Patents = 13

Forward Citations = 337

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Muneaki Takase (15 out of 15 patents)

Toshiyuki Matsuno (14 out of 15 patents)

Seiichiro Kawashima (11 out of 11 patents)

4. Shinichi Yaguchi (10 out of 10 patents)

5. Tetsuo Watanabe (9 out of 89 patents)

6. Hiroaki Yamazaki (9 out of 26 patents)

7. Kenichi Saitoh (9 out of 11 patents)

8. Kimitomo Yoshioka (9 out of 9 patents)

9. Yoshio Tsuchida (6 out of 6 patents)

10. Naoki Fukuda (4 out of 13 patents)

11. Yoshimasa Yamaguchi (4 out of 4 patents)

12. Hiroya Sasahara (4 out of 4 patents)

13. Hideshi Kobayashi (4 out of 4 patents)

14. Masayuki Takahashi (3 out of 53 patents)

15. Kazuhiko Haruta (3 out of 4 patents)

Core Competencies:

Antibody Production

Aptamer Technology

Purine Derivatives

Heterocyclic Compounds

Immunosuppressive Agents

Cerebral Function Improvers

Antitumor Agents

Cardiotonic Agents

Thiazole Derivatives

Polysaccharides

Pharmaceutical Compositions

Digestive Tract Coating

41 patents: Sort by Forward Citations

1. 10344099 - Antibody and antibody composition production method (2019-07-09),

2. 9850492 - Aptamer to IL-17 and use thereof (2017-12-26),

3. 9809645 - [object Object] (2017-11-07),

4. 9132130 - Purine derivative and antitumor agent using same (2015-09-15),

5. 9089561 - Methods for treating depression, neurodegeneration, inhibiting amyloid β deposition, delaying senescence, and extending life spans with heterocyclic compounds (2015-07-28),

6. 8563715 - Pyrimidine derivative having cell protecting effect and uses thereof (2013-10-22),

7. 8372890 - Functional food containing sodium tricaffeoylaldarate (2013-02-12),

8. 8338414 - Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient (2012-12-25),

9. 8227463 - Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same (2012-07-24),

10. 7855199 - Heterocyclic compound and anti-malignant-tumor agent containing the same as active ingredient (2010-12-21),

11. 7803947 - Method for producing thiocarbamate derivative (2010-09-28),

12. 7767824 - Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient (2010-08-03),

13. 7750001 - Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient (2010-07-06),

14. 7307077 - Heterocyclic compound and antitumor agent containing the same as effective ingredient (2007-12-11),

15. 7153853 - Heterocyclic compounds and antitumor drugs containing the same as the active ingredient (2006-12-26),

Zenyaku Kogyo Kabushiki Kaisha is a Japanese pharmaceutical company, specializing in the development, manufacturing, and sales of pharmaceutical products. With a focus on innovative research and technology, Zenyaku Kogyo strives to provide high-quality medications and contribute to the well-being of society. For more information, please visit our website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

41 Patents

#792 in Tokyo

#1,897 in Japan

#16,223 in the World

Zenyaku Kogyo Kabushiki Kaisha

Forward Citations = 337

78 inventors:

Muneaki Takase (15 out of 15 patents)

Toshiyuki Matsuno (14 out of 15 patents)

Seiichiro Kawashima (11 out of 11 patents)

4. Shinichi Yaguchi (10 out of 10 patents)

5. Tetsuo Watanabe (9 out of 89 patents)

Please report any incorrect information to support@idiyas.com

Loading…